Introduction Methods Results Conclusions References

Slides:



Advertisements
Similar presentations
Derby Hospitals Strategy. Overview  This is the story of how we set about creating a strategy for the next five years  It considers how the.
Advertisements

Disease State Management The Pharmacist’s Role
Jan Hull Acting Director of Development
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Stages of CKD – KDOQI 2002 Definitions
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality worldwide and in Singapore. In Singapore, there are about.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CARE Authors Institutions Authors: Silvia Martínez-Valverde MSc 1, Hortensia.
Population Health Janet Appel, RN, MSN Director of Informatics and Population Health.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Pharmacists Working In Primary Healthcare Centers: Are They Ready To Expand Their Role? Sinaa Alageel, MSc, PhD; Norah Abanmy MSc Department of Clinical.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
An Inter-Professional Collaboration between a Family Medicine Center and a School of Nursing Maritza De La Rosa, MD New Jersey Family Practice Center Rutgers,
Department of Preventive Medicine Faculty of Public Health University of Debrecen General Practitioners’ Morbidity Sentinel Stations Program (GPMSSP) to.
Survey of acute hospital resources for patients with COPD T McCarthy, M O’Connor, on behalf of the National COPD (Respiratory) Strategy Group Population.
Clinical Quality Improvement: Achieving BP Control
Shubhangi Arora1; Eden Haverfield2; Gabriele Richard2; Susanne B
Physician Associates in Primary Care
Prevalence of Chronic Kidney Disease among Older Adults in Urban Sri Lanka - Tip of the Iceberg? S T De Silva1,2, K T A A Kasturiratna3, S Chackrewarthy4.
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Our five year plan to improve local health and care services
Workforce Update Charlotte Lawson
NDA – THE LATEST DATA Prof Roger Gadsby MBE FRCGP Honorary Associate Clinical Professor , WMS GP Clinical Lead National Diabetes Audit.
Diabetes and Hypertension Health Screening in the Fresno Sikh Population: A Cross Sectional Approach Baljit Singh Dhesi 1,2 1University of California,
The Role of Depression in Effective Chronic Disease Management
GENERAL PRACTITIONER LANDSCAPE SURVEY 2011
Chapter 2: Identification and Care of Patients With CKD
Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.
Champlain LHIN Collaboration
2016 Annual Data Report, Vol 1, CKD, Ch 2
2017 Annual Data Report Healthy People 2020.
Chapter 1: CKD in the General Population
Better Start Oral Health Improvement Strategy Donna Taylor CECD Development Officer.
Prevalence of Chronic Kidney Disease among Older Adults in Urban Sri Lanka - Tip of the Iceberg? S T De Silva1,2, K T A A Kasturiratna3, S Chackrewarthy4.
Canada Needs PAs.
Presentation for Community Leadership
Kate Yorke, Project Manager – MECC
Canada Needs PAs.
Income for NHS Trusts. Income for NHS Trusts Expenditure NHS Trusts.
Providing sustainable resilient primary care
& RHP 15 Collaboration.
2018 Annual Data Report Volume 3: Healthy People 2020
Chapter 1: CKD in the General Population
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
Improving Outcomes by Helping People Take Control
Public Engagement Events
Canada Needs PAs.
Chapter 2: Identification and Care of Patients with CKD
Sue Glanfield Deputy Director of Service Development
Canada Needs PAs.
Presentation for Community Members
The Effect of Emergency Department Waiting Time
Canada Needs PAs.
Presentation for Health Care Staff & Health Stakeholders
Presentation for Community Leadership
Income for NHS Trusts. Income for NHS Trusts Expenditure NHS Trusts.
NEWS FOR OUR PATIENTS September 2017
Canada Needs PAs.
Canada Needs PAs.
KidneyWise Clinical Toolkit Launched May 2015
CROATIAN HEALTH INSURANCE FUND
MULTIDISCIPLINARY (MDT) APPROACH TO CLINICAL CARE MODEL FOR EFFECTIVE AND BEST EVIDENCE PATIENT CARE DR EZEKIEL ALAWALE MBBS, FWACS, FRCS(I), JCPTGP, GP.
Consultant Clinical Biochemist
Canada Needs PAs.
8_84 Apollo Sugar Clinic: Diabetes surveillance campaign Screening Population Based on Gender Apollo Sugar holds the Proprietary right for the content.
II PAHO-DOTA Workshop on Quality of Care of Diabetes Care
National Hospice and Palliative Care Organization Palliative Care Resource Series KEY CONSIDERATIONS FOR BRANDING AND MARKETING YOUR PALLIATIVE CARE.
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

Introduction Methods Results Conclusions References Right-siting chronic kidney disease care – a survey of primary care physicians in Singapore Pradeep Paul George1, Christina Ma OH2, Loh Ping Tyug3, Bee Hoon Heng1, Vathsala Andaraman3, Fong-Seng Lim4 1Health Services & Outcomes Research department, National Healthcare Group (NHG), Singapore, 2Disease Management, NHG , 3Division of Nephrology, National University Hospital Health System, Singapore, 4NHG Polyclinics Introduction Methods Results Figure 4. GP's Awareness of CKD guidelines Chronic kidney disease (CKD) and kidney failure are reaching pandemic proportions in Singapore. The aging population, higher prevalence of diabetes and hypertension are some factors that contribute to the increasing incidence of kidney disease. The effects of these factors are likely to increase in the years to come.1 Recently specialist outpatient clinics (SOC’s) in Singapore are facing increasing pressure to handle more appointment requests than before due to the aging and growing population.2 The lead time between an appointment request and the actual visit tends to be longer because the growth of SOC capacity cannot catch up with the increasing demand. Analysis of the workload and case mix of the renal specialist outpatient clinics (SOC’s) in Singapore General Hospital revealed that up to 30% of the patients seen had early kidney disease that could be managed in the community by family physicians.3 To ensure efficient and quality healthcare delivery for all, the healthcare system must ensure that patients are ‘right-sited’, i.e. they receive care in the most appropriate care setting for their medical needs, with the most efficient use of resources. This study aims to identify factors influencing screening and management of CKD among primary care physicians (PCP) in Singapore, in order to plan programme(s) to encourage their participation in the right-siting program. Three hundred and two GPs completed the questionnaire; response rate was 25%. Majority of the respondents were males (70%) and Chinese (92%) with their median duration of practice being 18 years. Of these, 86% reported screening patients for CKD, 76% attend to less than 10 CKD patients per year (Figure.2), 50% were confident of managing patients with CKD stage I, and 33% and 13% were confident in managing CKD stage 2 and stage 3, respectively (Table.1). Ten percent of GPs reported using serum creatinine, urinalysis (UFEME), random urine albumin creatinine ratio or urine creatinine ratio for CKD screening. Thirty eight percent of GPs are aware of CKD guidelines; only 27.5 % of them specified definite guidelines (Figure.4). Majority of GPs (64%) agreed that right-siting of early CKD patients would ease congestion at SOC clinics (Figure.3). Obstacles to CKD management that were listed by the GPs included the lack of patient trust, experience and communication with the specialist, and inability of the patient to pay. Motivational drivers of GPs towards CKD management included access to patient information, co-management with renal physician, more interaction with renal physicians and adequate remuneration for the time spent in managing CKD. A survey was conducted among the 1,202 GPs registered in the National Healthcare Group (NHG) GP Partner database (Figure.1). A questionnaire was developed in collaboration with experts in nephrology and general practice to achieve the study objectives. It covered knowledge about screening tests for CKD, awareness of CKD guidelines, confidence in managing CKD stage 1 - 3, and their opinion about right-siting CKD care from SOC’s to primary care. The questionnaire was faxed to the physicians and followed up with three telephonic reminders. Data was collected between April 2010 and September 2010. Conclusions Figure 2. CKD patients treated & managed per year The survey has identified factors that prevent and facilitate the wider acceptance of CKD right-siting by both the patients and the GPs. GPs screen for CKD, however their awareness of CKD guidelines is limited. Opportunities exist for improvement, which includes increasing physician recognition of CKD, awareness of the evidence-based CKD guidelines, improving collaborative care with nephrology and reimbursement for the patient and the provider. References Figure 1. Distribution of the surveyed GP’s Table 1. GP’s confidence in managing CKD (Stage I, II & III) Figure 3. GP's opinion on right-siting CKD care Vathsala A. Twenty-five facts about kidney disease in Singapore: in remembrance of World Kidney Day.Ann Acad Med Singapore. 2007 Mar;36(3):157-60. http://www.moh.gov.sg/mohcorp/pressreleases.aspx?id=964 [24 March 2010] Annual Report (2006). Centre for Health Services Research (CHSR).Available at http://www.singhealth.com.sg/research/healthservicesresearch/hsrannualreport/documents/chsrannualreport.pdf, Date accessed: May 12, 2011. Question: My confidence level in managing patients with Chronic Kidney Disease (CKD) CKD (%) Stage I Stage II Stage III Not confident at all 4 5 11 Not confident 12 20 37 Neutral 35 42 39 Quite confident 43 29 Very Confident 7 2